Somatic Gene Therapy for a Neurodegenerative Disease Using Microencapsulated Recombinant Cells
- 31 December 2000
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 166 (2) , 276-286
- https://doi.org/10.1006/exnr.2000.7531
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Evaluation of Reaction of Primate Brain to Grafted PC12 CellsCell Transplantation, 1999
- Delivery of Recombinant Gene Products to the Central Nervous System with Nonautologous Cells in Alginate MicrocapsulesHuman Gene Therapy, 1999
- Dose-Dependent Doxycycline-Mediated Adrenocorticotropic Hormone Secretion from Encapsulated Tet-On Proopiomelanocortin Neuro2A Cells in the Subarachnoid SpaceHuman Gene Therapy, 1998
- Long-Term Enhanced Chromaffin Cell Survival and Behavioral Recovery in Hemiparkinsonian Rats with Co-grafted Polymer-Encapsulated Human NGF-Secreting CellsExperimental Neurology, 1997
- Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's diseaseNature, 1997
- Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patientsNature Medicine, 1996
- Lysosomal storage diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995
- Behavioral consequences of bone marrow transplantation in the treatment of murine mucopolysaccharidosis type VII.Journal of Clinical Investigation, 1994
- Behavioural abnormalities in a murine model of a human lysosomal storage diseaseNeuroReport, 1993
- Beta glucuronidase deficiency: Report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosisThe Journal of Pediatrics, 1973